Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci

References

• Brin YS, Golenser J, Mizrahi B, et al (2008). Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release 131:121–7
   PubMed Web of Science ®Google Scholar
• Burygin GL, Khlebtsov BN, Shantrokha AN, et al (2009). On the enhanced antibacterial activity of antibiotics mixed with gold nanoparticles. Nanoscale Res Lett 4:794–801
   PubMed Web of Science ®Google Scholar
• Coates A, Hu Y, Bax R, Page C, (2002). The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 1:895–910
   PubMed Web of Science ®Google Scholar
• Delehanty JB, Boeneman K, Bradburne CE, et al (2010). Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery. Medintz Ther Deliv 1:411–33
   PubMedGoogle Scholar
• Dini E, Alexandridou S, Kiparissides C. (2003). Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications. J Microencapsul 3:375–85
   Google Scholar
• Duncan B, Kim C, Rotello VM. (2010). Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J. Control Release 148:122–7
   PubMed Web of Science ®Google Scholar
• El-Ansary A, Al-Daihan S. (2009). On the toxicity of therapeutically used nanoparticles: an overview. J Toxicol 2009:1–9
   Google Scholar
• EI-Sayed IH, Huang X, EI-Sayed MA. (2006). Selective laser photo-thermal therapy of carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 230:129–35
   Google Scholar
• Fayaz AM, Girilal M, Mahdy SA, et al (2011). Vancomycin bound biogenic gold nanoparticles: a different perspective for development of anti VRSA agents. Process Biochem 46:636–41
   Web of Science ®Google Scholar
• Gargani G, Pacetti AM. (1998). Sensitivity of 115 strains of the genus Brucella to some antibiotics (cephalosporins, ureidopenicillins and aminoglycosides). Chemioterapia 5:7–13
   Google Scholar
• Giljohann DA, Seferos DS, Daniel WL, et al (2010). Gold nanoparticles for biology and medicine. Angew Chem Int Ed 49:3280–94
   PubMed Web of Science ®Google Scholar
• Grace NA, Pandian K. (2007). Antibacterial efficacy of aminoglycosidic antibiotics protected gold nanoparticles—A brief study. Colloids Surf A Physicochem Eng Asp 297:63–70
   Web of Science ®Google Scholar
• Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM. (2006). Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 79:248–53
   PubMed Web of Science ®Google Scholar
• Hosta-Rigau L, Olmedo I, Arbiol J, et al (2010). Multifunctionalized gold nanoparticles with peptides targeted to gastrin-releasing peptide receptor of a tumor cell line. Bioconjugate Chem 21:1070–8
   PubMed Web of Science ®Google Scholar
• Kim HJ, Jones MN. (2004). The delivery of benzyl penicillin to Staphylococcus aureus biofilms by use of liposomes. J. Liposome Res 14:123–39
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discovery 9:615–27
   PubMed Web of Science ®Google Scholar
• Pissuwan D, Cortie CH, Valenzuela SM, Cortie MB. (2010). Functionalised gold nanoparticles for controlling pathogenic bacteria. Trends Biotechnol 28:207–13
   PubMed Web of Science ®Google Scholar
• Rubin RJ, Harrington CA, Poon A. (1999). The economic impact of S. aureus infection in NY City hospitals. Emerg Infect Dis 5:9–17
   PubMed Web of Science ®Google Scholar
• Saha B, Bhattacharya J, Mukherjee A, et al (2007). In vitro structural and functional evaluation of gold nanoparticles conjugated antibiotics. Nanoscale Res Lett 2:614–22
   Web of Science ®Google Scholar
• Selvaraj V, Alagar M. (2007). Analytical detection and biological assay of antileukemic drug 5-fluorouracil using gold nanoparticles as probe. Int J Pharm 337:275–81
   PubMed Web of Science ®Google Scholar
• Tulkens PM. (1986). Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives. Am J Med 80:105–14
   PubMed Web of Science ®Google Scholar
• Wang LY, Ma GH, Zhi-Guo S. (2005). Preparation of uniform sized chitosan microspheres by membrane emulsification technique and application as a carrier of protein drug. J Control Release 106:62–75
   PubMed Web of Science ®Google Scholar
• Zhang L, Pornpattananangkul D, Hu MJ, Huang M. (2010). Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem 17:585–94
   PubMed Web of Science ®Google Scholar